Centro Ricerche Cliniche di Verona s.r.l. c/o Policlinico G.B.Rossi-Site Number : 3800002

Verona, Veneto 37134

1 studies enrolling now · 1 studies all time

What they study most

Immunoglobulin G4 Related Disease

Studies at this site

• A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease — Recruiting now